Kumakura S, Oshima T
Jpn Heart J. 1975 Sep;16(5):592-602. doi: 10.1536/ihj.16.592.
Effects of 2 different types of beta blockers, CS-359 and practolol, on mechanical performance and myocardial oxygen consumption (MVO2) in the isovolumic contraction of the isolated, blood-perfused canine heart with a support dog were studied. Two dose levels of the beta blockers were given intravenously to the support dog, one of which was enough to produce a significant beta adrenergic blocking action and other of which was a higher dose to reveal a direct depressant action on the isolated heart. CS-359 in the lower dose produced significant decreases in heart rate (HR), peak ventricular systolic pressure (peak VSP), and peak dp/dt while practolol caused no change in these parameters. The HR of the support dog was significantly decreased to the same degree in the lower dose of respective blocker. In the higher dose CS-359 decreased all parameters more definitely whereas practolol diminished peak VSP and peak dp/dt but did not significantly HR. MVO2 was decreased dose-relatedly by CS-359, but not affected significantly by practolol. From the analysis of relationships of MVO2 to peak VSP and HR in the isolated heart it is concluded that the effective reduction in MVO2 by CS-359 resulted mainly from a reduction in the peak VSP in the lower dose and additional decrease in HR in the higher dose of CS-359.
研究了两种不同类型的β受体阻滞剂CS - 359和美多心安对在有辅助犬情况下的离体、血液灌注犬心脏等容收缩期机械性能和心肌耗氧量(MVO2)的影响。向辅助犬静脉注射两种剂量水平的β受体阻滞剂,其中一种剂量足以产生显著的β肾上腺素能阻断作用,另一种更高剂量用于揭示对离体心脏的直接抑制作用。较低剂量的CS - 359可使心率(HR)、心室收缩压峰值(peak VSP)和dp/dt峰值显著降低,而美多心安对这些参数无影响。在各自较低剂量的阻滞剂作用下,辅助犬的心率均显著降低至相同程度。在较高剂量时,CS - 359更明确地降低了所有参数,而美多心安降低了peak VSP和dp/dt峰值,但对心率无显著影响。CS - 359使MVO2呈剂量依赖性降低,但美多心安对其无显著影响。通过分析离体心脏中MVO2与peak VSP和HR的关系得出结论,CS - 359对MVO2的有效降低主要源于较低剂量时peak VSP的降低以及较高剂量CS - 359时心率的额外降低。